PHAT
Phathom Pharmaceuticals Inc
6.80$
+1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6,421.8% | -3,609.8% | -965.6% | -388.8% | -213.9% | -297.8% | -158.8% | -28.5% | -8.7% | -26.8% | -2.6% | -15.3% | |
| – | 27.1% | 11.2% | 2.7% | 1.2% | 0.7% | 0.6% | 0.4% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | |
| – | 3,604.7% | 294.2% | 83.3% | 34.5% | 22.5% | 19.4% | 20.9% | 18.8% | 9.7% | 9.5% | 9.0% | 11.3% | |
| – | 99.1% | -367.2% | -8.5% | 8.5% | -30.5% | -31.3% | -15.1% | -3.1% | 7.0% | 2.7% | 3.5% | 2.8% | |
| – | 69.6% | 2.1% | 0.6% | 0.5% | 0.0% | 0.1% | 0.2% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | |
| – | -69.6% | -2.1% | -0.6% | -0.3% | 0.0% | -0.1% | -0.2% | -0.1% | -0.2% | -0.1% | -0.1% | -0.1% | |
| – | – | – | – | 0.0% | 83.4% | 0.0% | 0.0% | 0.0% | 0.0% | -95.7% | 0.0% | -23.3% | |
| – | 31,084.0% | 517.8% | 338.2% | 746.4% | 87.8% | 0.0% | 0.2% | -0.5% | -0.2% | 114.3% | 4.8% | 29.1% | |
| – | 24,591.8% | -3,094.4% | -628.0% | 357.4% | -126.1% | -297.9% | -158.8% | -29.1% | -9.0% | 87.4% | 2.1% | 13.7% | |
| – | -6,491.5% | -3,611.9% | -966.2% | -388.3% | -213.9% | -297.9% | -158.8% | -28.6% | -8.5% | -26.9% | -2.7% | -15.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.